The effect of dose enhancement in tumor with silver nanoparticles on surrounding healthy tissues: A monte carlo study
| dc.authorid | 0000-0002-0106-7683 | |
| dc.authorid | 0009-0007-4120-0462 | |
| dc.authorid | 0009-0007-6923-4998 | |
| dc.contributor.author | Çağlar, Mustafa | |
| dc.contributor.author | Eşitmez, Dursun | |
| dc.contributor.author | Cebe, Mehmet Sıddık | |
| dc.date.accessioned | 2024-03-20T11:03:35Z | |
| dc.date.available | 2024-03-20T11:03:35Z | |
| dc.date.issued | 2024 | |
| dc.department | İstanbul Medipol Üniversitesi, Sağlık Bilimleri Enstitüsü, Sağlık Fiziği Ana Bilim Dalı | |
| dc.description.abstract | Objectives: Cancer-related death rates account for approximately one-third of all deaths, and this rate is increasing remarkably every year. In this study, we examined the dose enhancement factor (DEF) in the tumor and surrounding tissues by adding different concentrations of silver nanoparticles (AgNPs) to the brain tumor using the Monte Carlo (MC) technique. Methods: This study used MCNP6.2 simulation software. A Planning Target Volume (PTV) of 1 × 1 × 1 cm3 was placed in the center of a cubic cranial model with dimensions of 5 × 5 × 5 cm3. Five different simulations were initially generated using the simple method. These simulations included pure PTV and PTV consisting of 4 different silver concentrations (5, 10, 20, and 30?mg/g). Additionally, a model was created using the nanolattice method, considering the size, position, and distribution of the AgNPs. Irradiation was performed using a source with a 6 MV linac photon spectrum. Measurements were performed using the *f8 tally, and DEF values were calculated. Results: In the simulation study using the simple method, the DEF value of PTV increased linearly with concentration, whereas the DEF values were lower than the simulation results with the nanolattice model (1.9 vs 1.4 for 30?mg/g NP concentration). Performing the simple method, we observed no remarkable dose increase in lateral OARs surrounding PTV. While a remarkable dose decrease was observed in distal OARs, a dose increase in the proximal OAR was observed, which was consistent with that of PTV. However, according to the results obtained by performing the nanolattice method, the dose increase was observed in both the proximal OAR and the distal OAR and was similar to that of PTV. Conclusion: While enhancing the dose in the tumor by adding NPs into the tumor, it is essential to consider whether it also increases the OAR dose. In addition, simulation studies on NPs showed that the dose increase varied significantly with particle size, position, and distribution. Hence, these factors should be considered carefully. | |
| dc.identifier.citation | Çağlar, M., Eşitmez, D. ve Cebe, M. S. (2024). The effect of dose enhancement in tumor with silver nanoparticles on surrounding healthy tissues: A monte carlo study. Technology in Cancer Research and Treatment, 23. https://dx.doi.org/10.1177/15330338241235771 | |
| dc.identifier.doi | 10.1177/15330338241235771 | |
| dc.identifier.issn | 1533-0346 | |
| dc.identifier.issn | 1533-0338 | |
| dc.identifier.pmid | 38449099 | |
| dc.identifier.scopus | 2-s2.0-85186876412 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.uri | https://dx.doi.org/10.1177/15330338241235771 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/12381 | |
| dc.identifier.volume | 23 | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.institutionauthor | Çağlar, Mustafa | |
| dc.institutionauthor | Eşitmez, Dursun | |
| dc.institutionauthor | Cebe, Mehmet Sıddık | |
| dc.language.iso | en | |
| dc.publisher | SAGE Publications Inc. | |
| dc.relation.ispartof | Technology in Cancer Research and Treatment | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | Attribution-NonCommercial 4.0 International | * |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | * |
| dc.subject | DEF | |
| dc.subject | Doseenhancement Factor | |
| dc.subject | MCNP6.2 | |
| dc.subject | Monte Carlo Simulation | |
| dc.subject | Nanoparticles | |
| dc.subject | Organ at Risk | |
| dc.subject | Radiotherapy | |
| dc.subject | Silver Nanoparticle (AgNP) | |
| dc.title | The effect of dose enhancement in tumor with silver nanoparticles on surrounding healthy tissues: A monte carlo study | |
| dc.type | Article |
